{"id":"https://openalex.org/W2105527005","doi":"https://doi.org/10.1200/jco.2006.07.7016","title":"Randomized Phase II Trial of Pemetrexed Combined With Either Cisplatin or Carboplatin in Untreated Extensive-Stage Small-Cell Lung Cancer","display_name":"Randomized Phase II Trial of Pemetrexed Combined With Either Cisplatin or Carboplatin in Untreated Extensive-Stage Small-Cell Lung Cancer","publication_year":2006,"publication_date":"2006-10-18","ids":{"openalex":"https://openalex.org/W2105527005","doi":"https://doi.org/10.1200/jco.2006.07.7016","mag":"2105527005","pmid":"https://pubmed.ncbi.nlm.nih.gov/17050869"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2006.07.7016","doi":"https://doi.org/10.1200/jco.2006.07.7016","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2006.07.7016","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078629724","display_name":"Mark A. Socinski","orcid":"https://orcid.org/0000-0003-2915-9325","observed_orcids":["https://orcid.org/0000-0003-2915-9325","https://orcid.org/0000-0002-8213-0137"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I4210096972","display_name":"Los Angeles Medical Center","ror":"https://ror.org/00spys463","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343052199","https://openalex.org/I4210096972"]},{"id":"https://openalex.org/I4210107699","display_name":"Highlands Oncology Group","ror":"https://ror.org/01k1j7593","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210107699"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark A. Socinski","raw_affiliation_strings":["From the Lineberger Comprehensive Cancer Center, Multidisciplinary Thoracic Oncology Program, University of North Carolina at Chapel Hill, Chapel Hill; Alamance Regional Medical Center, Burlington, NC; US Oncology, Latham, NY; Florida Cancer Specialists, Fort Meyers, FL; Highlands Oncology Group, Fayetteville, AR; St Luke's Medical Center, Milwaukee, WI; University of California Los Angeles Medical Center, Los Angeles, CA; and Eli Lilly & Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Lineberger Comprehensive Cancer Center, Multidisciplinary Thoracic Oncology Program, University of North Carolina at Chapel Hill, Chapel Hill; Alamance Regional Medical Center, Burlington, NC; US Oncology, Latham, NY; Florida Cancer Specialists, Fort Meyers, FL; Highlands Oncology Group, Fayetteville, AR; St Luke's Medical Center, Milwaukee, WI; University of California Los Angeles Medical Center, Los Angeles, CA; and Eli Lilly & Company, Indianapolis, IN","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I161318765","https://openalex.org/I168537998","https://openalex.org/I4210096972","https://openalex.org/I4210107699","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Charles Weissman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I4210096972","display_name":"Los Angeles Medical Center","ror":"https://ror.org/00spys463","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343052199","https://openalex.org/I4210096972"]},{"id":"https://openalex.org/I4210107699","display_name":"Highlands Oncology Group","ror":"https://ror.org/01k1j7593","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210107699"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles Weissman","raw_affiliation_strings":["From the Lineberger Comprehensive Cancer Center, Multidisciplinary Thoracic Oncology Program, University of North Carolina at Chapel Hill, Chapel Hill; Alamance Regional Medical Center, Burlington, NC; US Oncology, Latham, NY; Florida Cancer Specialists, Fort Meyers, FL; Highlands Oncology Group, Fayetteville, AR; St Luke's Medical Center, Milwaukee, WI; University of California Los Angeles Medical Center, Los Angeles, CA; and Eli Lilly & Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Lineberger Comprehensive Cancer Center, Multidisciplinary Thoracic Oncology Program, University of North Carolina at Chapel Hill, Chapel Hill; Alamance Regional Medical Center, Burlington, NC; US Oncology, Latham, NY; Florida Cancer Specialists, Fort Meyers, FL; Highlands Oncology Group, Fayetteville, AR; St Luke's Medical Center, Milwaukee, WI; University of California Los Angeles Medical Center, Los Angeles, CA; and Eli Lilly & Company, Indianapolis, IN","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I161318765","https://openalex.org/I168537998","https://openalex.org/I4210096972","https://openalex.org/I4210107699","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111656761","display_name":"Lowell L. Hart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I4210096972","display_name":"Los Angeles Medical Center","ror":"https://ror.org/00spys463","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343052199","https://openalex.org/I4210096972"]},{"id":"https://openalex.org/I4210107699","display_name":"Highlands Oncology Group","ror":"https://ror.org/01k1j7593","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210107699"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lowell L. Hart","raw_affiliation_strings":["From the Lineberger Comprehensive Cancer Center, Multidisciplinary Thoracic Oncology Program, University of North Carolina at Chapel Hill, Chapel Hill; Alamance Regional Medical Center, Burlington, NC; US Oncology, Latham, NY; Florida Cancer Specialists, Fort Meyers, FL; Highlands Oncology Group, Fayetteville, AR; St Luke's Medical Center, Milwaukee, WI; University of California Los Angeles Medical Center, Los Angeles, CA; and Eli Lilly & Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Lineberger Comprehensive Cancer Center, Multidisciplinary Thoracic Oncology Program, University of North Carolina at Chapel Hill, Chapel Hill; Alamance Regional Medical Center, Burlington, NC; US Oncology, Latham, NY; Florida Cancer Specialists, Fort Meyers, FL; Highlands Oncology Group, Fayetteville, AR; St Luke's Medical Center, Milwaukee, WI; University of California Los Angeles Medical Center, Los Angeles, CA; and Eli Lilly & Company, Indianapolis, IN","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I161318765","https://openalex.org/I168537998","https://openalex.org/I4210096972","https://openalex.org/I4210107699","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003887338","display_name":"Joseph Thaddeus Beck","orcid":"https://orcid.org/0000-0002-3341-9903","observed_orcids":["https://orcid.org/0000-0002-3341-9903"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I4210096972","display_name":"Los Angeles Medical Center","ror":"https://ror.org/00spys463","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343052199","https://openalex.org/I4210096972"]},{"id":"https://openalex.org/I4210107699","display_name":"Highlands Oncology Group","ror":"https://ror.org/01k1j7593","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210107699"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Thaddeus Beck","raw_affiliation_strings":["From the Lineberger Comprehensive Cancer Center, Multidisciplinary Thoracic Oncology Program, University of North Carolina at Chapel Hill, Chapel Hill; Alamance Regional Medical Center, Burlington, NC; US Oncology, Latham, NY; Florida Cancer Specialists, Fort Meyers, FL; Highlands Oncology Group, Fayetteville, AR; St Luke's Medical Center, Milwaukee, WI; University of California Los Angeles Medical Center, Los Angeles, CA; and Eli Lilly & Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Lineberger Comprehensive Cancer Center, Multidisciplinary Thoracic Oncology Program, University of North Carolina at Chapel Hill, Chapel Hill; Alamance Regional Medical Center, Burlington, NC; US Oncology, Latham, NY; Florida Cancer Specialists, Fort Meyers, FL; Highlands Oncology Group, Fayetteville, AR; St Luke's Medical Center, Milwaukee, WI; University of California Los Angeles Medical Center, Los Angeles, CA; and Eli Lilly & Company, Indianapolis, IN","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I161318765","https://openalex.org/I168537998","https://openalex.org/I4210096972","https://openalex.org/I4210107699","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062335050","display_name":"J. K. Choksi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I4210096972","display_name":"Los Angeles Medical Center","ror":"https://ror.org/00spys463","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343052199","https://openalex.org/I4210096972"]},{"id":"https://openalex.org/I4210107699","display_name":"Highlands Oncology Group","ror":"https://ror.org/01k1j7593","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210107699"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janak K. Choksi","raw_affiliation_strings":["From the Lineberger Comprehensive Cancer Center, Multidisciplinary Thoracic Oncology Program, University of North Carolina at Chapel Hill, Chapel Hill; Alamance Regional Medical Center, Burlington, NC; US Oncology, Latham, NY; Florida Cancer Specialists, Fort Meyers, FL; Highlands Oncology Group, Fayetteville, AR; St Luke's Medical Center, Milwaukee, WI; University of California Los Angeles Medical Center, Los Angeles, CA; and Eli Lilly & Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Lineberger Comprehensive Cancer Center, Multidisciplinary Thoracic Oncology Program, University of North Carolina at Chapel Hill, Chapel Hill; Alamance Regional Medical Center, Burlington, NC; US Oncology, Latham, NY; Florida Cancer Specialists, Fort Meyers, FL; Highlands Oncology Group, Fayetteville, AR; St Luke's Medical Center, Milwaukee, WI; University of California Los Angeles Medical Center, Los Angeles, CA; and Eli Lilly & Company, Indianapolis, IN","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I161318765","https://openalex.org/I168537998","https://openalex.org/I4210096972","https://openalex.org/I4210107699","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":null,"display_name":"John P. Hanson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I4210096972","display_name":"Los Angeles Medical Center","ror":"https://ror.org/00spys463","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343052199","https://openalex.org/I4210096972"]},{"id":"https://openalex.org/I4210107699","display_name":"Highlands Oncology Group","ror":"https://ror.org/01k1j7593","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210107699"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John P. Hanson","raw_affiliation_strings":["From the Lineberger Comprehensive Cancer Center, Multidisciplinary Thoracic Oncology Program, University of North Carolina at Chapel Hill, Chapel Hill; Alamance Regional Medical Center, Burlington, NC; US Oncology, Latham, NY; Florida Cancer Specialists, Fort Meyers, FL; Highlands Oncology Group, Fayetteville, AR; St Luke's Medical Center, Milwaukee, WI; University of California Los Angeles Medical Center, Los Angeles, CA; and Eli Lilly & Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Lineberger Comprehensive Cancer Center, Multidisciplinary Thoracic Oncology Program, University of North Carolina at Chapel Hill, Chapel Hill; Alamance Regional Medical Center, Burlington, NC; US Oncology, Latham, NY; Florida Cancer Specialists, Fort Meyers, FL; Highlands Oncology Group, Fayetteville, AR; St Luke's Medical Center, Milwaukee, WI; University of California Los Angeles Medical Center, Los Angeles, CA; and Eli Lilly & Company, Indianapolis, IN","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I161318765","https://openalex.org/I168537998","https://openalex.org/I4210096972","https://openalex.org/I4210107699","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113698410","display_name":"Diane Prager","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I4210096972","display_name":"Los Angeles Medical Center","ror":"https://ror.org/00spys463","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343052199","https://openalex.org/I4210096972"]},{"id":"https://openalex.org/I4210107699","display_name":"Highlands Oncology Group","ror":"https://ror.org/01k1j7593","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210107699"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diane Prager","raw_affiliation_strings":["From the Lineberger Comprehensive Cancer Center, Multidisciplinary Thoracic Oncology Program, University of North Carolina at Chapel Hill, Chapel Hill; Alamance Regional Medical Center, Burlington, NC; US Oncology, Latham, NY; Florida Cancer Specialists, Fort Meyers, FL; Highlands Oncology Group, Fayetteville, AR; St Luke's Medical Center, Milwaukee, WI; University of California Los Angeles Medical Center, Los Angeles, CA; and Eli Lilly & Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Lineberger Comprehensive Cancer Center, Multidisciplinary Thoracic Oncology Program, University of North Carolina at Chapel Hill, Chapel Hill; Alamance Regional Medical Center, Burlington, NC; US Oncology, Latham, NY; Florida Cancer Specialists, Fort Meyers, FL; Highlands Oncology Group, Fayetteville, AR; St Luke's Medical Center, Milwaukee, WI; University of California Los Angeles Medical Center, Los Angeles, CA; and Eli Lilly & Company, Indianapolis, IN","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I161318765","https://openalex.org/I168537998","https://openalex.org/I4210096972","https://openalex.org/I4210107699","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003839820","display_name":"Matthew Monberg","orcid":"https://orcid.org/0009-0006-7462-4782","observed_orcids":["https://orcid.org/0009-0006-7462-4782"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I4210096972","display_name":"Los Angeles Medical Center","ror":"https://ror.org/00spys463","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343052199","https://openalex.org/I4210096972"]},{"id":"https://openalex.org/I4210107699","display_name":"Highlands Oncology Group","ror":"https://ror.org/01k1j7593","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210107699"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew J. Monberg","raw_affiliation_strings":["From the Lineberger Comprehensive Cancer Center, Multidisciplinary Thoracic Oncology Program, University of North Carolina at Chapel Hill, Chapel Hill; Alamance Regional Medical Center, Burlington, NC; US Oncology, Latham, NY; Florida Cancer Specialists, Fort Meyers, FL; Highlands Oncology Group, Fayetteville, AR; St Luke's Medical Center, Milwaukee, WI; University of California Los Angeles Medical Center, Los Angeles, CA; and Eli Lilly & Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Lineberger Comprehensive Cancer Center, Multidisciplinary Thoracic Oncology Program, University of North Carolina at Chapel Hill, Chapel Hill; Alamance Regional Medical Center, Burlington, NC; US Oncology, Latham, NY; Florida Cancer Specialists, Fort Meyers, FL; Highlands Oncology Group, Fayetteville, AR; St Luke's Medical Center, Milwaukee, WI; University of California Los Angeles Medical Center, Los Angeles, CA; and Eli Lilly & Company, Indianapolis, IN","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I161318765","https://openalex.org/I168537998","https://openalex.org/I4210096972","https://openalex.org/I4210107699","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063776208","display_name":"Zhishen Ye","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I4210096972","display_name":"Los Angeles Medical Center","ror":"https://ror.org/00spys463","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343052199","https://openalex.org/I4210096972"]},{"id":"https://openalex.org/I4210107699","display_name":"Highlands Oncology Group","ror":"https://ror.org/01k1j7593","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210107699"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhishen Ye","raw_affiliation_strings":["From the Lineberger Comprehensive Cancer Center, Multidisciplinary Thoracic Oncology Program, University of North Carolina at Chapel Hill, Chapel Hill; Alamance Regional Medical Center, Burlington, NC; US Oncology, Latham, NY; Florida Cancer Specialists, Fort Meyers, FL; Highlands Oncology Group, Fayetteville, AR; St Luke's Medical Center, Milwaukee, WI; University of California Los Angeles Medical Center, Los Angeles, CA; and Eli Lilly & Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Lineberger Comprehensive Cancer Center, Multidisciplinary Thoracic Oncology Program, University of North Carolina at Chapel Hill, Chapel Hill; Alamance Regional Medical Center, Burlington, NC; US Oncology, Latham, NY; Florida Cancer Specialists, Fort Meyers, FL; Highlands Oncology Group, Fayetteville, AR; St Luke's Medical Center, Milwaukee, WI; University of California Los Angeles Medical Center, Los Angeles, CA; and Eli Lilly & Company, Indianapolis, IN","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I161318765","https://openalex.org/I168537998","https://openalex.org/I4210096972","https://openalex.org/I4210107699","https://openalex.org/I4390039329"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016064449","display_name":"Coleman K. Obasaju","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I4210096972","display_name":"Los Angeles Medical Center","ror":"https://ror.org/00spys463","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343052199","https://openalex.org/I4210096972"]},{"id":"https://openalex.org/I4210107699","display_name":"Highlands Oncology Group","ror":"https://ror.org/01k1j7593","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210107699"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Coleman K. Obasaju","raw_affiliation_strings":["From the Lineberger Comprehensive Cancer Center, Multidisciplinary Thoracic Oncology Program, University of North Carolina at Chapel Hill, Chapel Hill; Alamance Regional Medical Center, Burlington, NC; US Oncology, Latham, NY; Florida Cancer Specialists, Fort Meyers, FL; Highlands Oncology Group, Fayetteville, AR; St Luke's Medical Center, Milwaukee, WI; University of California Los Angeles Medical Center, Los Angeles, CA; and Eli Lilly & Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Lineberger Comprehensive Cancer Center, Multidisciplinary Thoracic Oncology Program, University of North Carolina at Chapel Hill, Chapel Hill; Alamance Regional Medical Center, Burlington, NC; US Oncology, Latham, NY; Florida Cancer Specialists, Fort Meyers, FL; Highlands Oncology Group, Fayetteville, AR; St Luke's Medical Center, Milwaukee, WI; University of California Los Angeles Medical Center, Los Angeles, CA; and Eli Lilly & Company, Indianapolis, IN","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I161318765","https://openalex.org/I168537998","https://openalex.org/I4210096972","https://openalex.org/I4210107699","https://openalex.org/I4390039329"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":7.6263,"has_fulltext":false,"cited_by_count":82,"citation_normalized_percentile":{"value":0.98033786,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"24","issue":"30","first_page":"4840","last_page":"4847"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pemetrexed","display_name":"pemetrexed","score":0.8579999804496765},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9800000190734863},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":1.0},{"id":"https://openalex.org/keywords/extensive-stage-small-cell-lung-cancer","display_name":"extensive-stage small cell lung cancer","score":0.968999981880188},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.7730000019073486},{"id":"https://openalex.org/keywords/median-survival","display_name":"median survival time","score":0.5830000042915344},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.6700000166893005},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7519999742507935},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.6610000133514404},{"id":"https://openalex.org/keywords/dose-intensity","display_name":"dose intensity","score":0.42399999499320984},{"id":"https://openalex.org/keywords/treatment-response-rate","display_name":"treatment response rate","score":0.48100000619888306},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.45399999618530273}],"concepts":[{"id":"https://openalex.org/C2777240266","wikidata":"https://www.wikidata.org/wiki/Q415220","display_name":"Pemetrexed","level":4,"score":0.9945236444473267},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.910469114780426},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8623538017272949},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7134721279144287},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.673550546169281},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.666340708732605},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5875682830810547},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5772335529327393},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4543664753437042},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.41755396127700806},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.15370219945907593}],"mesh":[{"descriptor_ui":"D000068437","descriptor_name":"Pemetrexed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005971","descriptor_name":"Glutamates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006147","descriptor_name":"Guanine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006147","descriptor_name":"Guanine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018288","descriptor_name":"Carcinoma, Small Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018288","descriptor_name":"Carcinoma, Small Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2006.07.7016","doi":"https://doi.org/10.1200/jco.2006.07.7016","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2006.07.7016","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:17050869","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17050869","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320308982","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W24018398","https://openalex.org/W51813618","https://openalex.org/W205380934","https://openalex.org/W1550111394","https://openalex.org/W1910732341","https://openalex.org/W1923792259","https://openalex.org/W1964305008","https://openalex.org/W1973510243","https://openalex.org/W1976565907","https://openalex.org/W1988454321","https://openalex.org/W1989315499","https://openalex.org/W1996141967","https://openalex.org/W2005914700","https://openalex.org/W2007526924","https://openalex.org/W2009590627","https://openalex.org/W2034500838","https://openalex.org/W2041545692","https://openalex.org/W2073683299","https://openalex.org/W2102627969","https://openalex.org/W2103662507","https://openalex.org/W2110730246","https://openalex.org/W2113515867","https://openalex.org/W2114998251","https://openalex.org/W2115658330","https://openalex.org/W2125923404","https://openalex.org/W2127776375","https://openalex.org/W2134667653","https://openalex.org/W2139248078","https://openalex.org/W2142703207","https://openalex.org/W2163379812","https://openalex.org/W2171659308","https://openalex.org/W2229928428","https://openalex.org/W2248341615","https://openalex.org/W2323020638","https://openalex.org/W2339444986","https://openalex.org/W2345129137","https://openalex.org/W4231155808","https://openalex.org/W4235168276","https://openalex.org/W4246512333","https://openalex.org/W4293241248"],"related_works":["https://openalex.org/W2281489950","https://openalex.org/W2288014069","https://openalex.org/W1985293042","https://openalex.org/W2155723257","https://openalex.org/W2144712198","https://openalex.org/W2049872779","https://openalex.org/W2226373164","https://openalex.org/W2083424818","https://openalex.org/W2164678502","https://openalex.org/W2097268198"],"abstract_inverted_index":{"PURPOSE:":[0],"Given":[1],"the":[2,14,38,72,216,228,246],"activity":[3,257],"and":[4,13,96,104,128,153,177,197,211,219,223,240,248,258],"tolerability":[5],"of":[6,16,40,86,151,157,175,181],"pemetrexed/platinum":[7],"combinations":[8],"in":[9,21,46,215,227,245,263],"non-small-cell":[10],"lung":[11,25],"cancer,":[12],"success":[15],"novel":[17],"therapeutic":[18],"strategies":[19],"employed":[20],"recent":[22],"extensive-stage":[23],"small-cell":[24],"cancer":[26],"(ES-SCLC)":[27],"trials,":[28],"a":[29,84,148,154,172,178],"randomized":[30],"phase":[31],"II":[32],"trial":[33],"was":[34,77,118,144,168,194,200,207],"initiated":[35],"to":[36,57,123,133,162,186,190,260],"evaluate":[37],"use":[39],"cisplatin":[41,63,210],"or":[42,66],"carboplatin":[43,69,222],"plus":[44,62,68],"pemetrexed":[45,59,67,214,226],"previously":[47],"untreated":[48],"ES-SCLC.":[49,265],"PATIENTS":[50],"AND":[51],"METHODS:":[52],"Patients":[53],"were":[54,110],"randomly":[55],"assigned":[56],"receive":[58],"500":[60],"mg/m2":[61,65],"75":[64,134],"area":[70],"under":[71],"concentration":[73],"curve":[74],"5.":[75],"Treatment":[76],"administered":[78],"once":[79],"every":[80],"21":[81],"days":[82],"for":[83,126,136,142,166,192,198,209,213,221,225],"maximum":[85],"six":[87],"cycles.":[88],"All":[89],"patients":[90,109],"received":[91],"folic":[92],"acid,":[93],"vitamin":[94],"B12,":[95],"steroid":[97],"prophylaxis.":[98],"RESULTS:":[99],"Between":[100],"December":[101],"19,":[102],"2002,":[103],"May":[105],"17,":[106],"2004,":[107],"78":[108],"enrolled":[111],"onto":[112],"this":[113],"multicenter":[114],"trial.":[115],"Median":[116,138,188,203],"age":[117],"63":[119],"years":[120,130],"(range,":[121,131],"46":[122],"82":[124],"years)":[125,135],"cisplatin/pemetrexed":[127,143,193,217,247],"66":[129],"47":[132],"carboplatin/pemetrexed.":[137],"survival":[139],"time":[140,189],"(MST)":[141],"7.6":[145],"months,":[146,170],"with":[147,171],"1-year":[149,173],"survivorship":[150,174],"33.4%":[152],"response":[155,179],"rate":[156,180],"35%":[158],"(95%":[159,183],"CI,":[160,184],"20.6%":[161],"51.7%).":[163],"The":[164],"MST":[165],"carboplatin/pemetrexed":[167,199,229,249],"10.4":[169],"39.0%":[176],"39.5%":[182],"24.0":[185],"56.6).":[187],"progression":[191],"4.9":[195],"months":[196],"4.5":[201],"months.":[202],"dose-intensity":[204],"(actual/planned":[205],"dose)":[206],"98.94%":[208],"99.95%":[212],"group":[218],"93.21%":[220],"98.50%":[224],"group.":[230],"Grade":[231],"3/4":[232],"hematologic":[233],"toxicities":[234],"included":[235],"neutropenia":[236],"(15.8%":[237],"v":[238,243],"20.0%)":[239],"thrombocytopenia":[241],"(13.2%":[242],"22.9%)":[244],"treatment":[250],"groups,":[251],"respectively.":[252],"CONCLUSION:":[253],"Pemetrexed/platinum":[254],"doublets":[255],"had":[256],"appeared":[259],"be":[261],"well-tolerated":[262],"first-line":[264]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}